Jacobs Lab In the Division of Oncology

Publications

1972 - 1979 | 1980 - 1989 | 1990 - 1999 | 2000 -

1. DeCroes C*, Abood LG. Histology of a uniquely organized nervous system in the salamander neural tissue-limb implant. Int J Neurosci 1972;3:237-50.

2. Jacobs C, Portlock CS, Rosenberg SA. Prednisone in MOPP chemotherapy for Hodgkin's disease. Br Med J 1976;2:1469-71.

3. Kim H, Jacobs C, Warnke RA, Dorfman RF. Malignant lymphoma with high content of epitheloid histiocytes. Cancer 1978;41:620-35.

4. Jacobs C, Bertino JR, Goffinet DR, Fee WE, Goode RL. Cis-platinum chemotherapy in head and neck cancers. Otolaryngol Head Neck Surg 1978;86:780-3.

5. Jacobs C, Bertino JR, Goffinet DR, Fee WE, Goode RL. 24-hour infusion of cis-platinum in head and neck cancers. Cancer 1978;42:2135-40.

6. Jacobs C. A patient teaching tool - Hodgkin's disease. Cancer Nursing 1979;2:153-66.

1980

7. Levi J, Jacobs C, Kalman SM, McTigue M, Weiner MW. Mechanism of cis-platinum nephrotoxicity: I. Effects on sulfhydryl groups in rat kidneys. J Pharmacol Exp Ther 1980;213:545-50.

8. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther 1980;213:551-6.

9. Jacobs C, Kalman SM, Tretton M, Weiner MW. Renal handling of cis-diamminedichloroplatinum (II). Cancer Treat Rep 1980;64:1223-6.

10. Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the pregnant patient with Hodgkin's disease. Ann Intern Med 1981;95:669-75.

11. Mead GM, Jacobs C. Changing role of chemotherapy in the treatment of head and neck cancer. Am J Med 1982;73:582-95.

12. Jacobs C. Chemotherapy and combined modality treatment of head and neck cancer. Current Concepts in Oncology, 1982:4:17-21.

13. Jacobs C. Use of methotrexate and 5-FU for recurrent head and neck cancer. Cancer Treat Rep 1982;66:1925-8.

14. Jacobs C, Ross RD, Walker IM, Stockdale FE. Behavior of cancer patients: A randomized study of the effects of education and peer support groups. Am J Clin Oncol 1983;6:347-50.

15. Jacobs C, Meyers F, Hendrickson C, Kohler M, Carter S. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. Cancer 1983;52:1563-9.

*Maiden Name

16. Campbell AB, Kalman SM, Jacobs C. Plasma platinum levels: Relationship to cisplatin dose and nephrotoxicity. Cancer Treat Rep 1983;67:169-72.

17. Coleman CN, Friedman MK, Jacobs C, Halsey J, Ignoffo R, Leibel S, Hirst VK, Gribble M, Carter SK, Phillips TL. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer Misonidazole. Cancer Res 1983;43:5022-5.

18. Jacobs C, Coleman CN, Rich L, Hirst K. Weiner MW. Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid. Cancer Res 1984;44:3632-5.

19. Schreiber DP, Jacobs C, Rosenberg SA, Cox RS, Hoppe RT. The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas. Int J Radiat Oncol Biol Phys 1985;11:31-6.

20. Jacobs C, Hoppe RT. Non-Hodgkin's lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 1985;11:357-64.

21. Connors JM, Andiman WA, Howarth CB, Liu E, Merigan TC, Savage ME, Jacobs C. Treatment of nasopharyngeal carcinoma with human leukocyte interferon. J Clin Oncol 1985;3:813-7.

22. Kent DL, Shortliffe EH, Carlson RW, Bischoff MB, Jacobs CD. Improvements in data collection through physician use of a computer-based chemotherapy treatment consultant. J Clin Oncol 1985;3:1409-17.

23. Hickam DH, Shortliffe EH, Bischoff MB, Scott AC, Jacobs CD. The treatment advice of a computer-based cancer chemotherapy protocol advisor. Ann Intern Med 1985;103:928-36.

24. Jacobs C, Weiss L, Hoppe RT. The management of extranodal head and neck lymphomas. Arch Otolaryngol Head Neck Surg 1986;112:654-8.

25. Bernstein JI, Jacobs C, Meyers F, Rich-Goffinet L, Tanaka L. A phase II study of cisplatin and cytosine arabinoside for recurrent squamous cell carcinoma of the head and neck. Am J Clin Oncol 1986;9:58-60.

26. Fu KK, Phillips TL, Silverberg IJ, Jacobs C, Goffinet DR, Chun C, Friedman MA, Kohler M, McWhirter K, Carter SK. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987;5:1410-8.

27. Tseng A Jr., Jacobs C, Coleman CN, Horning SJ, Lewis BJ, Rosenberg SA. Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate. Cancer Treat Rep 1987;71:475-8.

28. Venook AP, Tseng A Jr., Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: A pilot study of the Northern California Oncology Group. J Clin Oncol 1987;5:951-5.

29. Jacobs C. Treatment of recurrent squamous cell head and neck cancer. Advances in Oncology 1987;3:16-22.

30. Jacobs C.* Adjuvant chemotherapy for advanced head and neck squamous carcinoma. A Final Report of the Head and Neck Contracts Program. Cancer 1987;60:301-11.

31. Jacobs C, Goffinet DR, Goffinet L, Kohler M, Fee W. Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 1987;60:1178-83.

32. Tseng A Jr., Jacobs C, Coleman CN, Horning SJ, Lewis BJ, Rosenberg SA. Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin. Cancer Treat Rep 1987;71:659-60.

33. Coleman CN, Carlson RW, Halsey J, Kohler M, Gribble M, Sikic BI, Jacobs C. Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole. Cancer Res 1988;48:3528-32.

34. Levick S, Jacobs C, Loukas DF, Gordon DH, Meyskens FL, Uhm K. Naproxen sodium in treatment of bone pain due to metastatic cancer. Pain 1988;35:253-8.

35. Dimery IW, Jacobs C, Tseng A, Saks S, Pearson G, Hong WK, Gutterman JU. Recombinant5interferon-gamma?in the treatment of recurrent nasopharyngeal carcinoma. J Biol Resp Mod 1989;8:221-6.

1990

36. Audeh MW, Jacobs CD, Davis TE, Carlson RW. A phase II trial of carbetimer for the treatment of colorectal cancer: a trial of the Northern California Oncology Group. Am J Cln Oncol. 1990;13(4): 324-6.

37. Jacobs C, Makuch R.. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer - a subset analysis of the head and neck contracts program. J Clin Oncol 1990;8:838-47.

38. Berry JM, Jacobs C, Sikic BI,Halsey J, Borch R. Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oncol 1990;8:1585-90 .

39. Jacobs C. The internist in the management of head and neck cancer. Ann Intern Med 1990;113(10):771-8.

40. Jacobs C, Kaubisch S, Halsey J, Lum B, Gosland M, Coleman CN, Sikic B. Use of probenecid as a chemoprotector against cisplatin nephrotoxicity. Cancer 1991;67(6):1518-24.

41. Vokes EE, Dimery I, Jacobs CD, et al. A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer. Cancer 1991 67(9):2253-57.

42. Jacobs C. Neoadjuvant and adjuvant treatment of head and neck cancer. Seminars in Oncology 1991;18:504-14.

* Writing Committee

43. Jacobs C, Lyman G, Velez-Garcia, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992;10:257-63.

44. Nelson M, Jacobs C, Cuban L. Concepts of Curriculum. Teaching and Learning in Medicine 1992;4:202-5

45. Jacobs C, Moreno B, Blaschke T. In Progress: A multimodality approach to preparation for clinical medicine. Acad Med 1995;70(5):441-2.

46. Jacobs C, Bergen M. In Progress: A sexual harassment workshop for medical students. Acad Med 1995;70(5):434-5.

47. Jacobs C, Pinto H. Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter. Seminars in Oncology 1995;22(6):540-52.

48. Jacobs CD, Cross PC. The value of medical student research — the experience at Stanford University School of Medicine. Medical Education 1995;29:342-6.

49. Bergen MR, Guarino CM, Jacobs CJ. A climate survey for medical students: a means to assess change. Evaluation and the Health Professions 1996;19(1):30-47.

50. Smith K, Moreno E, Jacobs C. The curriculum indexing database for Stanford University School of Medicine. Teaching and Learning in Med 1996; 8(1): 48-52.

51. Jacobs CJ, Van der Pas M. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia. Oncol 1996; 10:16-20.

52. Amer Soc Clin Oncol (Mayer RJ, Antman KH, Bailes JS, Bloomfield CD, Canellos GP, Glick JG, Jacobs CD). Status of the Medical Oncology Workforce. J Clin Onc 1996;14(9):2612-21.

53. Vosti KL, Bloch DA, Jacobs CD. The relationship of clinical knowledge to months of clinical training among medical students. Acad Med 1997;72(4):305-7.

54. Ciesielski-Carlucci C, Leong P, Jacobs C. A case report of anaphylaxis from cisplatin/taxol and a review of their hypersensitivity reaction profiles. Am J Clin Onc 1997;20(4):373-5.

55. Hausdorff J, Davis E, Long G, Hoppe R, van der Pas M, Lassman C, Kamel O, Jacobs C. Non-Hodgkin’s lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Cancer J Sci Am 1997;3(5):303-11.

56. Vosti KL, Jacobs CD. Outcome measurements in postgraduate year one of graduates from a medical school with a pass/fail grading system. Acad Med 1999;74(5):547-9.

57. Yuen A, Jacobs C. Lymphomas of the Head and Neck. Sem in Oncol 1999;26(3): 338-45.

2000

58. Jacobs CD, Bergen MR, Korn D. Impact of a program to diminish gender insensitivity and sexual harassment at a medical school. Acad Med 2000;75:464-9.

59. Nguyen DD, Loo BW Jr, Tillman G, Natkunam Y, Cao TM, Vaughan W, Dorfman RF, Goffinet DR, Jacobs CD, Advani RH. Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report Ann Hematol. 2003 Aug;82(8):521-5. Epub 2003 May 29.

top

 

Stanford Medicine Resources:

Footer Links: